| scholarly article | Q13442814 |
| P2093 | author name string | Alfieri C | |
| Allison AC | |||
| Kieff E | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A | Q28131712 | ||
| Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice | Q33388349 | ||
| Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy | Q34330594 | ||
| Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line | Q35207789 | ||
| The Role ofde novoPurine Synthesis in Lymphocyte Transformation | Q39875922 | ||
| Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis | Q40217046 | ||
| Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. | Q40834086 | ||
| In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. | Q41688262 | ||
| Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion | Q41698111 | ||
| Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease | Q43936463 | ||
| RS-61443--a new, potent immunosuppressive agent | Q45300416 | ||
| Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines | Q45797211 | ||
| Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: Kinetics of EBNA expression, cellular DNA synthesis, and mitosis | Q45802455 | ||
| T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. | Q45807697 | ||
| Early events in Epstein-Barr virus infection of human B lymphocytes | Q45855126 | ||
| Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. | Q46059909 | ||
| Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents | Q46179275 | ||
| RS-61443--a phase I clinical trial and pilot rescue study | Q67513704 | ||
| Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis | Q68893694 | ||
| Purification, characterization, and kinetic analysis of inosine 5'-monophosphate dehydrogenase of Tritrichomonas foetus | Q69903622 | ||
| Biological consequences of guanine starvation | Q69944876 | ||
| Contributions of the depletions of guanine and adenine nucleotides to the toxicity of purine starvation in the mouse T lymphoma cell line | Q70983639 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 126-129 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes | |
| P478 | volume | 38 |
| Q45747489 | Antiquity of Epstein-Barr virus, Sjögren's syndrome, and Hodgkin's disease--historical concordance and discordance |
| Q34977875 | EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding |
| Q38061056 | Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms |
| Q44061780 | Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study |
| Q36209765 | Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents? |
| Q33957177 | Mycophenolate mofetil and its mechanisms of action |
| Q45238640 | Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication |
| Q73044047 | Mycophenolate mofetil--a new treatment for autoimmune hepatitis? |
| Q34516425 | Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis |
| Q33957200 | The use of mycophenolate mofetil in transplant recipients |
| Q28477101 | Virtual high-throughput screening identifies mycophenolic acid as a novel RNA capping inhibitor |
Search more.